Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease

Matrix Biology

Volumn 35, Issue , 2014, Pages 162-173

  Chang, Mary Y ^a   Tanino, Yoshinori ^b   Vidova, Veronika ^a   Kinsella, Michael G ^c   Chan, Christina K ^c   Johnson, Pamela Y ^c   Wight, Thomas N ^c   Frevert, Charles W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Hyaluronan; Lung; Macrophage; TLR 4; Versican

Indexed keywords

CHLOROQUINE; HYALURONAN SYNTHASE 1; HYALURONAN SYNTHASE 2; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; ISOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; PROTEOCHONDROITIN SULFATE; SYNTHETASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRADATION; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TURNOVER TIME; UPREGULATION; WILD TYPE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; NEGIBACTERIA;

EID: 84901459609     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2014.04.003     Document Type: Article

References (79)

1. Agren U.M., Tammi R., Tammi M. A dot-blot assay of metabolically radiolabeled hyaluronan. Anal. Biochem. 1994, 217:311-315.
2. Austin J.W., Gilchrist C., Fehlings M.G. High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation. J. Neurochem. 2012, 122:344-355.
3. Bensadoun E.S., Burke A.K., Hogg J.C., Roberts C.R. Proteoglycan deposition in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1996, 154:1819-1828.
4. Bensadoun E.S., Burke A.K., Hogg J.C., Roberts C.R. Proteoglycans in granulomatous lung diseases. Eur. Respir. J. 1997, 10:2731-2737.
5. Berg J.T., Lee S.T., Thepen T., Lee C.Y., Tsan M.F. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphonate. J. Appl. Physiol. 1993, 74:2812-2819.
6. Blackwood R.A., Cantor J.O., Moret J., Mandl I., Turino G.M. Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc. Soc. Exp. Biol. Med. 1983, 174:343-349.
7. Bollyky P.L., Falk B.A., Wu R.P., Buckner J.H., Wight T.N., Nepom G.T. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 2009, 86:567-572.
8. Bollyky P.L., Bogdani M., Bollyky J.B., Hull R.L., Wight T.N. The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr. Diab. Rep. 2012, 12:471-480.
9. Brannen A.L., Chandler D.B. Alveolar macrophage subpopulations' responsiveness to chemotactic stimuli. Am. J. Pathol. 1988, 132:161-166.
10. Cattaruzza S., Schiappacassi M., Ljungberg-Rose A., Spessotto P., Perissinotto D., Morgelin M., Mucignat M.T., Colombatti A., Perris R. Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J. Biol. Chem. 2002, 277:47626-47635.
11. Chang M.Y., Chan C.K., Braun K.R., Green P.S., O'Brien K.D., Chait A., Day A.J., Wight T.N. Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J. Biol. Chem. 2012, 287:14122-14135.
12. Cheng G., Swaidani S., Sharma M., Lauer M.E., Hascall V.C., Aronica M.A. Correlation of Hyaluronan Deposition with Infiltration of Eosinophils and Lymphocytes in a Cockroach-Induced Murine Model of Asthma. Glycobiology 2013, 23:43-58.
13. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001, 20:499-508.
14. Day A.J., de la Motte C.A. Hyaluronan cross-linking: a protective mechanism in inflammation?. Trends Immunol. 2005, 26:637-643.
15. de Medeiros Matsushita M., da Silva L.F., dos Santos M.A., Fernezlian S., Schrumpf J.A., Roughley P., Hiemstra P.S., Saldiva P.H., Mauad T., Dolhnikoff M. Airway proteoglycans are differentially altered in fatal asthma. J. Pathol. 2005, 207:102-110.
16. DeGrendele H.C., Estess P., Picker L.J., Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 1996, 183:1119-1130.
17. Duan M., Li W.C., Vlahos R., Maxwell M.J., Anderson G.P., Hibbs M.L. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J. Immunol. 2012, 189:946-955.
18. Edelstam G.A., Laurent U.B., Lundkvist O.E., Fraser J.R., Laurent T.C. Concentration and turnover of intraperitoneal hyaluronan during inflammation. Inflammation 1992, 16:459-469.
19. Esko J.D., Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 2001, 108:169-173.
20. Evanko S.P., Angello J.C., Wight T.N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1004-1013.
21. Evanko S.P., Potter-Perigo S., Bollyky P.L., Nepom G.T., Wight T.N. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol. 2012, 31:90-100.
22. Faggian J., Fosang A.J., Zieba M., Wallace M.J., Hooper S.B. Changes in versican and chondroitin sulfate proteoglycans during structural development of the lung. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R784-R792.
23. Forteza R., Lieb T., Aoki T., Savani R.C., Conner G.E., Salathe M. Hyaluronan serves a novel role in airway mucosal host defense. FASEB J. 2001, 15:2179-2186.
24. Franz S., Allenstein F., Kajahn J., Forstreuter I., Hintze V., Moller S., Simon J.C. Artificial extracellular matrices composed of collagen 1 and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages. Acta Biomater. 2013, 9:5621-5629.
25. Frevert C.W., Matute-Bello G., Skerrett S.J., Goodman R.B., Kajikawa O., Sittipunt C., Martin T.R. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J. Immunol. 2000, 164:5439-5445.
26. Frey H., Schroeder N., Manon-Jensen T., Iozzo R.V., Schaefer L. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J. 2013, 280:2165-2179.
27. Fukuzumi M., Shinomiya H., Shimizu Y., Ohishi K., Utsumi S. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infect. Immun. 1996, 64:108-112.
28. Gill S., Wight T.N., Frevert C.W. Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat. Rec. (Hoboken) 2010, 293:968-981.
29. Hajjar A.M., Ernst R.K., Fortuno E.S., Brasfield A.S., Yam C.S., Newlon L.A., Kollmann T.R., Miller S.I., Wilson C.B. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog. 2012, 8:e1002963.
30. Hall C.L., Wang C., Lange L.A., Turley E.A. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol. 1994, 126:575-588.
31. Hallgren R., Samuelsson T., Laurent T.C., Modig J. Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1989, 139:682-687.
32. Hattori N., Carrino D.A., Lauer M.E., Vasanji A., Wylie J.D., Nelson C.M., Apte S.S. Pericellular versican regulates the fibroblast-myofibroblast transition: a role for ADAMTS5 protease-mediated proteolysis. J. Biol. Chem. 2011, 286:34298-34310.
33. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., Shinomura T., Hamaguchi M., Yoshida Y., Ohnuki Y., Miyauchi S., Spicer A.P., McDonald J.A., Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 1999, 274:25085-25092.
34. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., Noble P.W. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
35. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 2007, 23:435-461.
36. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
37. Jokela T.A., Jauhiainen M., Auriola S., Kauhanen M., Tiihonen R., Tammi M.I., Tammi R.H. Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines. J. Biol. Chem. 2008, 283:7666-7673.
38. Karlinsky J.B. Glycosaminoglycans in emphysematous and fibrotic hamster lungs. Am. Rev. Respir. Dis. 1982, 125:85-88.
39. Kassim S.Y., Gharib S.A., Mecham B.H., Birkland T.P., Parks W.C., McGuire J.K. Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect. Immun. 2007, 75:5640-5650.
40. Kim S., Takahashi H., Lin W.W., Descargues P., Grivennikov S., Kim Y., Luo J.L., Karin M. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
41. Koay M.A., Gao X., Washington M.K., Parman K.S., Sadikot R.T., Blackwell T.S., Christman J.W. Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin. Am. J. Respir. Cell Mol. Biol. 2002, 26:572-578.
42. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
43. Lemire J.M., Chan C.K., Bressler S., Miller J., LeBaron R.G., Wight T.N. Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells. J. Cell. Biochem. 2007, 101:753-766.
44. Lennon F.E., Singleton P.A. Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L137-L147.
45. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
46. Malmstrom J., Larsen K., Hansson L., Lofdahl C.G., Norregard-Jensen O., Marko-Varga G., Westergren-Thorsson G. Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study. Proteomics 2002, 2:394-404.
47. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
48. Mapleson J.L., Buchwald M. Effect of cycloheximide and dexamethasone phosphate on hyaluronic acid synthesis and secretion in cultured human skin fibroblasts. J. Cell. Physiol. 1981, 109:215-222.
49. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
50. Matute-Bello G., Frevert C.W., Liles W.C., Nakamura M., Ruzinski J.T., Ballman K., Wong V.A., Vathanaprida C., Martin T.R. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect. Immun. 2001, 69:5768-5776.
51. Meran S., Thomas D., Stephens P., Martin J., Bowen T., Phillips A., Steadman R. Involvement of hyaluronan in regulation of fibroblast phenotype. J. Biol. Chem. 2007, 282:25687-25697.
52. Merrilees M.J., Ching P.S., Beaumont B., Hinek A., Wight T.N., Black P.N. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir. Res. 2008, 9:41.
53. Monzon M.E., Fregien N., Schmid N., Falcon N.S., Campos M., Casalino-Matsuda S.M., Forteza R.M. Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. J. Biol. Chem. 2010, 285:26126-26134.
54. Nettelbladt O., Hallgren R. Hyaluronan (hyaluronic acid) in bronchoalveolar lavage fluid during the development of bleomycin-induced alveolitis in the rat. Am. Rev. Respir. Dis. 1989, 140:1028-1032.
55. Nettelbladt O., Tengblad A., Hallgren R. Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am. J. Physiol. 1989, 257:L379-L384.
56. Nielsen M.J., Madsen M., Moller H.J., Moestrup S.K. The macrophage scavenger receptor CD163: endocytic properties of cytoplasmic tail variants. J. Leukoc. Biol. 2006, 79:837-845.
57. Olin K.L., Potter-Perigo S., Barrett P.H., Wight T.N., Chait A. Lipoprotein lipase enhances the binding of native and oxidized low density lipoproteins to versican and biglycan synthesized by cultured arterial smooth muscle cells. J. Biol. Chem. 1999, 274:34629-34636.
58. Parish C.R. The role of heparan sulphate in inflammation. Nat. Rev. Immunol. 2006, 6:633-643.
59. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
60. Potter-Perigo S., Johnson P.Y., Evanko S.P., Chan C.K., Braun K.R., Wilkinson T.S., Altman L.C., Wight T.N. Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am. J. Respir. Cell Mol. Biol. 2010, 43:109-120.
61. Schonherr E., Jarvelainen H.T., Sandell L.J., Wight T.N. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 1991, 266:17640-17647.
62. Schonherr E., Jarvelainen H.T., Kinsella M.G., Sandell L.J., Wight T.N. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. 1993, 13:1026-1036.
63. Sheng W., Wang G., Wang Y., Liang J., Wen J., Zheng P.S., Wu Y., Lee V., Slingerland J., Dumont D., Yang B.B. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 2005, 16:1330-1340.
64. Skerrett S.J., Liggitt H.D., Hajjar A.M., Ernst R.K., Miller S.I., Wilson C.B. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L143-L152.
65. Strieter R.M., Belperio J.A., Keane M.P. Cytokines in innate host defense in the lung. J. Clin. Invest. 2002, 109:699-705.
66. Tammi R., Rilla K., Pienimaki J.P., MacCallum D.K., Hogg M., Luukkonen M., Hascall V.C., Tammi M. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J. Biol. Chem. 2001, 276:35111-35122.
67. Tammi R.H., Passi A.G., Rilla K., Karousou E., Vigetti D., Makkonen K., Tammi M.I. Transcriptional and post-translational regulation of hyaluronan synthesis. FEBS J. 2011, 278:1419-1428.
68. Tanino Y., Chang M.Y., Wang X., Gill S.E., Skerrett S., McGuire J.K., Sato S., Nikaido T., Kojima T., Munakata M., Mongovin S., Parks W.C., Martin T.R., Wight T.N., Frevert C.W. Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 2012, 47:196-202.
69. Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004, 4:528-539.
70. Underhill C.B., Nguyen H.A., Shizari M., Culty M. CD44 positive macrophages take up hyaluronan during lung development. Dev. Biol. 1993, 155:324-336.
71. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 2002, 14:617-623.
72. Wight T.N. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front. Biosci. 2008, 13:4933-4937.
73. Wilkinson T.S., Potter-Perigo S., Tsoi C., Altman L.C., Wight T.N. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 2004, 31:92-99.
74. Wu Y.J., La Pierre D.P., Wu J., Yee A.J., Yang B.B. The interaction of versican with its binding partners. Cell Res. 2005, 15:483-494.
75. Yamagata M., Kimata K. Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J. Cell Sci. 1994, 107(Pt 9):2581-2590.
76. Yamagata M., Suzuki S., Akiyama S.K., Yamada K.M., Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem. 1989, 264:8012-8018.
77. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
78. Yuan H., Tank M., Alsofyani A., Shah N., Talati N., LoBello J.C., Kim J.R., Oonuki Y., de la Motte C.A., Cowman M.K. Molecular mass dependence of hyaluronan detection by sandwich ELISA-like assay and membrane blotting using biotinylated hyaluronan binding protein. Glycobiology 2013, 23:1270-1280.
79. Zheng P.S., Vais D., Lapierre D., Liang Y.Y., Lee V., Yang B.L., Yang B.B. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J. Cell Sci. 2004, 117:5887-5895.